Affiliation:
1. J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611, USA
Abstract
Oxidative stress is an important, but elusive, therapeutic target for osteoarthritis (OA). Antioxidant strategies that target oxidative stress through the elimination of reactive oxygen species (ROS) have been widely evaluated for OA but are limited by the physiological characteristics of the joint. Current hallmarks in antioxidant treatment strategies include poor bioavailability, poor stability, and poor retention in the joint. For example, oral intake of exogenous antioxidants has limited access to the joint space, and intra-articular injections require frequent dosing to provide therapeutic effects. Advancements in ROS-scavenging nanomaterials, also known as nanozymes, leverage bioactive material properties to improve delivery and retention. Material properties of nanozymes can be tuned to overcome physiological barriers in the knee. However, the clinical application of these nanozymes is still limited, and studies to understand their utility in treating OA are still in their infancy. The objective of this review is to evaluate current antioxidant treatment strategies and the development of nanozymes as a potential alternative to conventional small molecules and enzymes.
Funder
National Institutes of Health
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference210 articles.
1. Osteoarthritis: A disease of the joint as an organ;Loeser;Arthritis Rheum.,2012
2. Osteoarthritis Pathogenesis: A Review of Molecular Mechanisms;Xia;Calcif. Tissue Int.,2014
3. Osteoarthritis Pathophysiology;Vincent;Clin. Geriatr. Med.,2022
4. Estimating the burden of total knee replacement in the United States;Weinstein;J. Bone Jt. Surg.,2013
5. The evaluation of oxidative stress in osteoarthritis;Zahan;Med. Pharm. Rep.,2020